RHN001 / RH Nanopharma - LARVOL DELTA

Development of Kit-Composition for the Preparation of [99mTc]Tc-PSMA-GCK01 / RHN001-DX (EANM 2024) - "We have successfully adapted a reagent composition for the kit based production of [99mTc]Tc-PSMA-GCK01. Temperature and heating conditions were chosen "conservatively", so that the final kit will provide the product in a broad temperature range of 90 ± 10 °C and reaction times of approx. 15 minutes."

Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers (clinicaltrials.gov) - P1 | N=64 | Completed | Sponsor: RH Nanopharmaceuticals

New P1 trial